pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,899 catalysts · 6,552 phase readout · 2,341 8k filing · 388 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 0 catalysts2026-08-18: 0 catalysts2026-08-19: 30 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout6,552
  • 8k filing2,341
  • earnings388
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›NOT_YET_RECRUITINGphase readoutNCT07623759: Early Diagnostic Telehealth Pilot for Moderate- and High-Risk Children: Evaluating Assessment Protocols and Efficiency in Georgia's Early Intervention Program

Sponsor: Emory University. Phase: NA. Conditions: Autism Spectrum Disorder, Autism

full page →ctgov ↗
›RECRUITINGphase readoutNCT07385196: Defining Ileorectal Syndrome: a Prospective Observational Study

Sponsor: Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital. Phase: . Conditions: Total Colectomy, Diarrhea, Urgency Incontinence, Soilings, Fecal

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04590235: A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)

Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Neurofibromatosis 1, Neurofibroma Plexiform

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03473743: A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer

Sponsor: Janssen Research & Development, LLC. Phase: PHASE1. Conditions: Urothelial Carcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05206617: 3 Year Follow up on ANO5 Patients

Sponsor: Rigshospitalet, Denmark. Phase: . Conditions: Neuromuscular Diseases, Limb Girdle Muscular Dystrophy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03104517: Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence

Sponsor: Cook MyoSite. Phase: PHASE3. Conditions: Stress Urinary Incontinence

full page →ctgov ↗
›COMPLETEDphase readoutNCT07510763: Piriformis and Gluteal Muscle Thickness in Patients With Unilateral Greater Trochanteric Pain Syndrome

Sponsor: Ankara Etlik City Hospital. Phase: . Conditions: Greater Trochanteric Pain Syndrome, Deep Gluteal Syndrome, Gluteal Tendinopathy

full page →ctgov ↗
›COMPLETEDphase readoutNCT06014099: Research on the Application of Blood Collection Through Midline Catheters of Different Lengths

Sponsor: Sir Run Run Shaw Hospital. Phase: NA. Conditions: Catheter Complications

full page →ctgov ↗
›RECRUITINGphase readoutNCT03356132: An Analysis of Adverse Events and Satisfaction Outcomes of Women Who Underwent Primary and Secondary Breast Augmentation Using Silimed® Breast Implants

Sponsor: Silimed Industria de Implantes Ltda. Phase: . Conditions: Breast Implant; Complications, Quality of Life, Satisfaction

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07356232: Partial Enteral Nutrition as Therapeutic Augmentation of Advanced Pharmacological Therapy in Patients With Active Crohn's Disease

Sponsor: University of Pennsylvania. Phase: NA. Conditions: Crohn's Disease, Active

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07534787: Clinical and Radiographic Evaluation of Ridge Splitting With Simultaneous Implant Placement Covered With Concentrated Growth Factor Membranes in Narrow Alveolar Ridge

Sponsor: Cairo University. Phase: NA. Conditions: Narrow Alveolar Ridge, CGF Concentrated Growth Factor, Postoperative Pain, Implant Placement

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03899987: Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery

Sponsor: Roswell Park Cancer Institute. Phase: PHASE2. Conditions: Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Stage IIA Prostate Cancer AJCC v8, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8

full page →ctgov ↗
›RECRUITINGphase readoutNCT06711887: Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

Sponsor: Novartis Pharmaceuticals. Phase: PHASE3. Conditions: Lupus Nephritis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06579287: A Study of SHJ002 Sterile Ophthalmic Solution for Myopia Control

Sponsor: Sunhawk Vision Biotech, Inc.. Phase: PHASE2. Conditions: Myopia, Progressive

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03687593: Safety and Performance Using Legion™ CR Oxinium and CoCr Femoral Implants Combined With Legion™/Genesis™ II XLPE High Flex Tibial Inserts

Sponsor: Smith & Nephew, Inc.. Phase: . Conditions: Total Knee Arthroplasty

full page →ctgov ↗
›COMPLETEDphase readoutNCT06709521: Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE4. Conditions: Bacterial Infection

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07637006: Linzhi Jianghuang Fufang Huoxue Anshen Capsule for Non-alcoholic Fatty Liver

Sponsor: Hong Kong Baptist University. Phase: PHASE2. Conditions: Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07566806: Evaluation of the Clinical Efficacy and Mechanisms of Cord Plasma Eye Drops in the Treatment of Neuropathic Corneal Pain

Sponsor: Singapore Eye Research Institute. Phase: NA. Conditions: Neuropathic Pain, Corneal Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT00959647: A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study

Sponsor: Genentech, Inc.. Phase: PHASE2. Conditions: Ovarian Cancer, Basal Cell Carcinoma, Metastatic Colorectal Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07355049: The Effect of Dexmedetomidine Versus Lidocaine on Emergence Agitation.

Sponsor: Fayoum University. Phase: NA. Conditions: Emergence Agitation

full page →ctgov ↗
›COMPLETEDphase readoutNCT07160049: Wearable Focused Ultrasound Stimulation for Peripheral Nerve Pain Management

Sponsor: Evan (Huiliang) Wang. Phase: NA. Conditions: Pain Management, Peripheral Neuropathic Pain

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06825338: Does the 'CATCH My Breath' Vaping Prevention Program Prevent High School Students in Ontario, Canada From Starting to Vape?

Sponsor: University of Ontario Institute of Technology. Phase: NA. Conditions: Vaping Behaviors

full page →ctgov ↗
›TERMINATEDphase readoutNCT05055258: A Trial to Evaluate the Efficacy and Safety of Different Doses of KVD824 for Prophylactic Treatment of HAE Type I or II

Sponsor: KalVista Pharmaceuticals, Ltd.. Phase: PHASE2. Conditions: Angioedema, Hereditary, Types I and II

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05073926: Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis

Sponsor: Region Skane. Phase: . Conditions: Latent Tuberculosis, Staphylococcus Aureus

full page →ctgov ↗
›RECRUITINGphase readoutNCT06480578: An Integrated Intervention Using a Pill Ingestible Sensor System

Sponsor: University of California, Los Angeles. Phase: PHASE2. Conditions: HIV/AIDS, Medication Adherence, Social Determinants of Health (SDOH)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06265285: Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Sponsor: Mayo Clinic. Phase: PHASE2. Conditions: Advanced Esophageal Squamous Cell Carcinoma, Advanced Renal Cell Carcinoma, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage IIB Cutaneous Melanoma AJCC v8, Clinical Stage IIC Cutaneous Melanoma AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8, Esophageal Carcinoma, Gastroesophageal Junction Adenocarcinoma, Hepatocellular Carcinoma, Locally Advanced Urothelial Carcinoma, Lung Non-Small Cell Carcinoma, Malignant Solid Neoplasm, Metastatic Colorectal Carcinoma, Metastatic Cutaneous Melanoma, Metastatic Esophageal Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Urothelial Carcinoma, Recurrent Esophageal Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8, Stage IV Renal Cell Cancer AJCC v8, Unresectable Cutaneous Melanoma, Unresectable Esophageal Squamous Cell Carcinoma, Urothelial Carcinoma, Unresectable Urothelial Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07436143: Effects of Posture and Quality of Life in Duchenne Muscular Dystrophy Children

Sponsor: Riphah International University. Phase: NA. Conditions: Child, Only

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07468643: Gingival Crevicular Fluid Biomarkers and Healing After Root Canal Treatment in Asymptomatic Apical Periodontitis

Sponsor: Faculty of Dental Medicine for Girls. Phase: . Conditions: Pulp and Periapical Tissue Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT04788615: Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS

Sponsor: Novartis Pharmaceuticals. Phase: PHASE3. Conditions: Multiple Sclerosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT06199635: Early Feasibility for Safety & Device Functionality of SFM Anastomosis Device Used in 3 Procedures (SNAP-S) or (SNAP-PS) or (J-J)

Sponsor: GI Windows, Inc.. Phase: NA. Conditions: Morbid Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07127835: Provocation After Nurse-Directed Assessment (PANDA) Study

Sponsor: The University of Hong Kong. Phase: . Conditions: Drug Allergy, Penicillin Allergy

full page →ctgov ↗
›COMPLETEDphase readoutNCT04322435: Prevalence of Hypoglycaemia in Congenital Adrenal Insufficiency

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Adrenal Insufficiency, Congenital

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03680508: TSR-022 (Anti-TIM-3 Antibody) and TSR-042 (Anti-PD-1 Antibody) in Patients With Liver Cancer

Sponsor: University of Hawaii. Phase: PHASE2. Conditions: Adult Primary Liver Cancer, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05434325: TESTING -ON Post-Trial ObservatioNal Cohort Study

Sponsor: The George Institute. Phase: . Conditions: IgA Nephropathy, ESRD, Glomerulonephritis, Kidney Diseases

full page →ctgov ↗
›WITHDRAWNphase readoutNCT06252376: Effects of Blood Pressure on Cognition and Cerebral Hemodynamics in PD

Sponsor: University of California, San Diego. Phase: NA. Conditions: Parkinson Disease, Orthostatic Hypertension, Cognitive Change, Cognitive Impairment, Cognitive Decline

full page →ctgov ↗
›RECRUITINGphase readoutNCT07270276: The Impact of Dry Needling on Electrophysiological and Ultrasound-based Biomarkers for Myofascial Pain

Sponsor: Beth Israel Deaconess Medical Center. Phase: NA. Conditions: Trigger Point in Trapezius Muscle

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05922917: Pulsed-field Ablation in Patients With Persistent Atrial Fibrillation

Sponsor: České Budějovice Hospital. Phase: NA. Conditions: Persistent Atrial Fibrillation, Pulsed-field Ablation

full page →ctgov ↗
›RECRUITINGphase readoutNCT07563517: Linking Individuals Needing Care for Substance Use Disorders to Peer Coaches & Across INcarceration Settings

Sponsor: Emory University. Phase: NA. Conditions: Substance Use

full page →ctgov ↗
›RECRUITINGphase readoutNCT07144917: Immunoparalysis After Pancreaticoduodenectomy

Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Pancreatic Ductal Adenocarcinoma (mPDAC), Pancreatic Head Tumour, Pancreatic Fistula

full page →ctgov ↗
›COMPLETEDphase readoutNCT07119840: Comparison Of Clinical Effects Of Listerine And Chlorhexidine Mouth Wash In Patients Undergoing Fixed Orthodontic Treatment

Sponsor: Khyber Medical University Peshawar. Phase: NA. Conditions: Gingivitis, Dental Plaque

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07673640: Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study

Sponsor: ShanShan Li. Phase: . Conditions: Non-Segmental Vitiligo (NSV)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07580989: Network Effects of Left M1 rTMS: A TMS-EEG Study

Sponsor: Aalborg University. Phase: NA. Conditions: Cortical Plasticity

full page →ctgov ↗
›RECRUITINGphase readoutNCT06743789: Trial in Arrhythmia Radioablation for Ventricular Tachycardia: Single Fraction vs Three Fractions

Sponsor: Weill Medical College of Cornell University. Phase: NA. Conditions: Ventricular Tachycardia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06395389: A Brief Intervention for Cannabis Use

Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Cannabis Use Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06527950: Anterior Mandibular Region for Immediate Implant Placement

Sponsor: Cairo University. Phase: . Conditions: Dental Implants

full page →ctgov ↗
›RECRUITINGphase readoutNCT07350850: A Multicenter, Prospective Clinical Trial With a Concurrent Control Evaluating Methotrexate Combined With Rituximab,Sintilimab and Pirtobrutinib vs. Investigator-Selected Standard of Care in Treatment-Naive PCNSL

Sponsor: Tongji Hospital. Phase: PHASE2. Conditions: PCNSL, Primary Central Nervous System Lymphoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04563650: COVID-19 Serology and Immunosenescence

Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: NA. Conditions: Covid19, Geriatric Medicine, Seroconversion, Immunosenescence

full page →ctgov ↗
›COMPLETEDphase readoutNCT07455474: Clinical Research Study of the Benefits of BREG Polar Care Wave to Reduce Opioid Use by Patients Having Undergone Arthroscopic Rotator Cuff Repair Shoulder Surgery

Sponsor: University of Nevada, Reno. Phase: NA. Conditions: Rotator Cuff Tear

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07616518: Dynamic Trajectories of Pupillary Light Reflex Parameters and Prognosis in Critically Ill Patients: A Multicenter Prospective Cohort Study

Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine. Phase: . Conditions: Critical Illness, Pupillometry, Prognosis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07524218: Effect of Meal Timing During Adjuvant Treatment for Cancer

Sponsor: Fred Hutchinson Cancer Center. Phase: NA. Conditions: Cancer

full page →ctgov ↗
← prev
page 177 of 178
next →